TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer.

Christine M Parseghian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.